FDA recall, , Moderate risk
Versiti Illinois Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced had a platelet count higher than acceptable.
Recall ended Sep 28, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Versiti Illinois Inc recalled Apheresis Platelets, Leukocytes Reduced because the product had a platelet count higher than was acceptable. The company began the recall on May 28, 2025. The FDA added the recall to its Enforcement Report on September 28, 2026. The product was distributed in Illinois and Indiana.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
- Affected units
- W039725540638 (2nd and 3rd containers of a triple collection); W039725540635 (3rd container of a triple collection)
Recall details
- Company began the recall
- Company
- Versiti Illinois Inc
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99201
- Recall number
- B-0130-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
